7 news items
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA
22 Jul 24
goal of submitting an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) by the end of this year which, if granted
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA
15 Jul 24
," "goal," "intends," "may," "plans," "possible," "potential," "seeks
MIRA Announces Positive Test Results
MIRA
17 Jun 24
to be delivered orally.
These results should enable the company to achieve its stated goal of having an IND submission to the FDA for Ketamir-2
Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year
MIRA
10 Jun 24
Novel Oral ketamine Analog, Ketamir-2The highly encouraging study results further MIRA's goal
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
MIRA
29 May 24
such as "Aims," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal
zu7uaemfb33gurh7hpfe
MIRA
21 May 24
," "expects," "forecasts," "goal," "intends," "may," "plans," "possible," "potential
h2fpr z3ukv5d0en5ud1avng6tq3mpr5nojtd2c03rh7
MIRA
20 May 24
," "anticipates," "believes," "could," "estimates," "expects," "forecasts," "goal," "intends
- Prev
- 1
- Next